Sanjib Chowdhury, PhD, MS
Research Assistant Professor
Boston University School of Medicine
Dept of Medicine

PhD, University of Nebraska Medical Center
MS, University of Nebraska Medical Center
MSc, University of Calcutta

Dr. Sanjib Chowdhury is a Research Assistant Professor for the BU School of Medicine in the Section of Gastroenterology. Dr. Chowdhury received his PhD in Cancer Research and MS in Clinical & Translational Research from the University of Nebraska Medical Center, where he was previously an Assistant Professor of Surgery. He also attended the University of Calcutta where he received an MS & BS in Human Physiology.
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Sommer CA, Capilla A, Molina-Estevez FJ, Gianotti-Sommer A, Skvir N, Caballero I, Chowdhury S, Mostoslavsky G. Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells. PLoS One. 2018; 13(7):e0200657.View Related Profiles. PMID: 30024920.
  2. Datta S, Sherva RM, De La Cruz M, Long MT, Roy P, Backman V, Chowdhury S, Roy HK. Single Nucleotide Polymorphism Facilitated Down-Regulation of the Cohesin Stromal Antigen-1: Implications for Colorectal Cancer Racial Disparities. Neoplasia. 2018 03; 20(3):289-294.View Related Profiles. PMID: 29471289; DOI: 10.1016/j.neo.2018.01.003;.
  3. Roy P, Chowdhury S, Roy HK. Exercise-induced myokines as emerging therapeutic agents in colorectal cancer prevention and treatment. Future Oncol. 2018 02; 14(4):309-312.View Related Profiles. PMID: 29318900.
  4. Robb CM, Kour S, Contreras JI, Agarwal E, Barger CJ, Rana S, Sonawane Y, Neilsen BK, Taylor M, Kizhake S, Thakare RN, Chowdhury S, Wang J, Black JD, Hollingsworth MA, Brattain MG, Natarajan A. Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 2018 Jan 12; 9(4):5216-5232. PMID: 29435174.
  5. Bailey KL, Agarwal E, Chowdhury S, Luo J, Brattain MG, Black JD, Wang J. TGFß/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells. PLoS One. 2017; 12(4):e0176096. PMID: 28414818; DOI: 10.1371/journal.pone.0176096;.
  6. Datta S, Chowdhury S, Roy HK. Metabolism, microbiome and colorectal cancer. Aging (Albany NY). 2017 Apr; 9(4):1086-1087.View Related Profiles. PMID: 28455972; DOI: 10.18632/aging.101234;.
  7. Cruz MD, Ledbetter S, Chowdhury S, Tiwari AK, Momi N, Wali RK, Bliss C, Huang C, Lichtenstein D, Bhattacharya S, Varma-Wilson A, Backman V, Roy HK. Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis. Oncotarget. 2017 Mar 28; 8(13):20543-20557.View Related Profiles. PMID: 28423551; DOI: 10.18632/oncotarget.16129;.
  8. Are C, Meyer B, Stack A, Ahmad H, Smith L, Qian B, Song T, Chowdhury S. Global trends in the burden of liver cancer. J Surg Oncol. 2017 Apr; 115(5):591-602. PMID: 28345140; DOI: 10.1002/jso.24518;.
  9. Douaiher J, Ravipati A, Grams B, Chowdhury S, Alatise O, Are C. Colorectal cancer-global burden, trends, and geographical variations. J Surg Oncol. 2017 Apr; 115(5):619-630. PMID: 28194798; DOI: 10.1002/jso.24578;.
  10. Are C, Ahmad H, Ravipati A, Croo D, Clarey D, Smith L, Price RR, Butte JM, Gupta S, Chaturvedi A, Chowdhury S. Global epidemiological trends and variations in the burden of gallbladder cancer. J Surg Oncol. 2017 Apr; 115(5):580-590. PMID: 28138977; DOI: 10.1002/jso.24546;.
Showing 10 of 28 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 28 publications over 7 distinct years, with a maximum of 9 publications in 2017

Contact for Mentoring:

650 Albany St Evans Biomed Research Ctr
Boston MA 02118
Google Map

Chowdhury's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department